Control Bionics (ASX:CBL) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics 5-Year EBITDA Growth Rate?

Control Bionics's EBITDA per Share for the six months ended in Jun. 2024 was A$-0.02.

During the past 3 years, the average EBITDA Per Share Growth Rate was 13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Control Bionics was 13.60% per year. The lowest was 13.60% per year. And the median was 13.60% per year.

Competitive Comparison of Control Bionics's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Control Bionics's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Control Bionics's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Control Bionics's 5-Year EBITDA Growth Rate falls into.

Control Bionics 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Control Bionics (ASX:CBL) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Control Bionics 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Control Bionics's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.